Healthcare Triangle (HCTI) Stock Forecast, Price Target & Predictions
HCTI Stock Forecast
Healthcare Triangle stock forecast is as follows: a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
HCTI Analyst Ratings
According to 1 Wall Street analysts, Healthcare Triangle's rating consensus is 'Buy'. The analyst rating breakdown for HCTI stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 28, 2022 | EF Hutton | Buy | Buy | Hold |
Healthcare Triangle's last stock rating was published by EF Hutton on Sep 28, 2022. The company gave HCTI a "Buy" rating, the same as its previous rate.
Healthcare Triangle Financial Forecast
Healthcare Triangle Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | $7.78M | $8.53M | $9.84M | $11.29M | $11.95M | - | $11.06M |
| Avg Forecast | $3.03M | $2.98M | $4.11M | $14.80M | $14.50M | $13.60M | $12.90M | $12.40M | $12.60M | $11.70M | $10.40M |
| High Forecast | $3.03M | $2.98M | $4.11M | $14.80M | $14.50M | $13.60M | $12.90M | $12.98M | $12.60M | $11.70M | $10.40M |
| Low Forecast | $3.03M | $2.98M | $4.11M | $14.80M | $14.50M | $13.60M | $12.90M | $11.82M | $12.60M | $11.70M | $10.40M |
| # Analysts | - | - | - | - | - | - | 1 | 1 | - | - | - |
| Surprise % | - | - | - | - | 0.54% | 0.63% | 0.76% | 0.91% | 0.95% | - | 1.06% |
Healthcare Triangle's average Quarter revenue forecast for Dec 23 based on 0 analysts is $14.80M, with a low forecast of $14.80M, and a high forecast of $14.80M. HCTI's average Quarter revenue forecast represents a 90.26% increase compared to the company's last Quarter revenue of $7.78M (Sep 23).
Healthcare Triangle EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | 1 | 1 | - | - | - |
| EBITDA | - | - | - | - | $-812.00K | $-1.18M | $-2.33M | $-3.85M | $-1.34M | - | $-1.26M |
| Avg Forecast | $-145.82K | $-143.71K | $-197.89K | $-712.78K | $-698.33K | $-654.99K | $-621.27K | $-597.19K | $-606.83K | $-563.48K | $-1.26M |
| High Forecast | $-145.82K | $-143.71K | $-197.89K | $-712.78K | $-698.33K | $-654.99K | $-621.27K | $-569.26K | $-606.83K | $-563.48K | $-1.01M |
| Low Forecast | $-145.82K | $-143.71K | $-197.89K | $-712.78K | $-698.33K | $-654.99K | $-621.27K | $-625.12K | $-606.83K | $-563.48K | $-1.52M |
| Surprise % | - | - | - | - | 1.16% | 1.79% | 3.76% | 6.45% | 2.20% | - | 1.00% |
undefined analysts predict HCTI's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Healthcare Triangle's previous annual EBITDA (undefined) of $NaN.
Healthcare Triangle Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | 1 | 1 | - | - | - |
| Net Income | - | - | - | - | $-1.94M | $-1.79M | $-3.28M | $-4.86M | $-2.34M | - | $-2.01M |
| Avg Forecast | $8.19M | $7.14M | $7.02M | $-1.06M | $-1.59M | $-1.59M | $-2.13M | $-2.13M | $-2.13M | $-2.23M | $-2.01M |
| High Forecast | $8.19M | $7.14M | $7.02M | $-1.06M | $-1.59M | $-1.59M | $-2.13M | $-2.13M | $-2.13M | $-2.23M | $-1.61M |
| Low Forecast | $8.19M | $7.14M | $7.02M | $-1.06M | $-1.59M | $-1.59M | $-2.13M | $-2.13M | $-2.13M | $-2.23M | $-2.41M |
| Surprise % | - | - | - | - | 1.22% | 1.12% | 1.54% | 2.29% | 1.10% | - | 1.00% |
Healthcare Triangle's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. HCTI's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Healthcare Triangle SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | 1 | 1 | - | - | - |
| SG&A | - | - | - | - | $2.46M | $2.64M | $3.39M | $2.90M | $3.29M | - | $3.09M |
| Avg Forecast | $649.84K | $640.42K | $881.87K | $3.18M | $3.11M | $2.92M | $2.77M | $2.66M | $2.70M | $2.51M | $3.09M |
| High Forecast | $649.84K | $640.42K | $881.87K | $3.18M | $3.11M | $2.92M | $2.77M | $2.79M | $2.70M | $2.51M | $3.71M |
| Low Forecast | $649.84K | $640.42K | $881.87K | $3.18M | $3.11M | $2.92M | $2.77M | $2.54M | $2.70M | $2.51M | $2.47M |
| Surprise % | - | - | - | - | 0.79% | 0.90% | 1.22% | 1.09% | 1.22% | - | 1.00% |
Healthcare Triangle's average Quarter SG&A projection for Dec 23 is $3.18M, based on 0 Wall Street analysts, with a range of $3.18M to $3.18M. The forecast indicates a 28.86% rise compared to HCTI last annual SG&A of $2.46M (Sep 23).
Healthcare Triangle EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | 1 | 1 | - | - | - |
| EPS | - | - | - | - | $-0.46 | $-0.00 | $-0.08 | $-0.13 | $-0.06 | - | $-0.06 |
| Avg Forecast | $1.54 | $1.34 | $1.58 | $-0.20 | $-0.30 | $-0.30 | $-0.40 | $-0.40 | $-0.40 | $-0.50 | $-0.50 |
| High Forecast | $1.54 | $1.34 | $1.58 | $-0.20 | $-0.30 | $-0.30 | $-0.40 | $-0.40 | $-0.40 | $-0.50 | $-0.50 |
| Low Forecast | $1.54 | $1.34 | $1.58 | $-0.20 | $-0.30 | $-0.30 | $-0.40 | $-0.40 | $-0.40 | $-0.50 | $-0.50 |
| Surprise % | - | - | - | - | 1.53% | 0.00% | 0.20% | 0.33% | 0.16% | - | 0.11% |
According to undefined Wall Street analysts, Healthcare Triangle's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to HCTI previous annual EPS of $NaN (undefined).
HCTI Forecast FAQ
Is Healthcare Triangle a good buy?
Yes, according to 1 Wall Street analysts, Healthcare Triangle (HCTI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of HCTI's total ratings.
Did the HCTI's actual financial results beat the analysts' financial forecasts?
Based on Healthcare Triangle's last annual report (Dec 2023), the company's revenue was $33.2M, which missed the average analysts forecast of $55.8M by -40.50%. Apple's EBITDA was $-6.11M, beating the average prediction of $-2.687M by 127.36%. The company's net income was $-12.339M, beating the average estimation of $-6.38M by 93.41%. Apple's SG&A was $10.09M, missing the average forecast of $11.98M by -15.71%. Lastly, the company's EPS was $-0.0029, missing the average prediction of $-1.2 by -99.76%. In terms of the last quarterly report (Sep 2023), Healthcare Triangle's revenue was $7.78M, missing the average analysts' forecast of $14.5M by -46.35%. The company's EBITDA was $-812K, beating the average prediction of $-698K by 16.28%. Healthcare Triangle's net income was $-1.943M, beating the average estimation of $-1.595M by 21.82%. The company's SG&A was $2.46M, missing the average forecast of $3.11M by -20.79%. Lastly, the company's EPS was $-0.46, beating the average prediction of $-0.3 by 53.33%